Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
EV/Core EBITDA

    Back to All Ratios
VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 5.752.905.004.895.34

What is the latest EV/Core EBITDA ratio of VENUS REMEDIES ?

The latest EV/Core EBITDA ratio of VENUS REMEDIES is 5.75 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar20245.75
Mar20232.90
Mar20225.00
Mar20214.89
Mar20205.34

How is EV/Core EBITDA of VENUS REMEDIES Trending?

Years EV/Core EBITDA % Change
Mar2024 5.75
98.28
Mar2023 2.9
-42.00
Mar2022 5
2.25
Mar2021 4.89
-8.43
Mar2020 5.34 -

Other Financial Ratios of VENUS REMEDIES


Compare EV/Core EBITDA ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹709.3 Cr 0.9% 23.4% 44.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,620.0 Cr -1.3% 1% 7.9% Stock Analytics
DIVIS LABORATORIES ₹175,509.0 Cr -3.2% -0.3% 48% Stock Analytics
TORRENT PHARMACEUTICALS ₹118,571.0 Cr 1.2% 10.7% 19.5% Stock Analytics
CIPLA ₹118,336.0 Cr -0.6% -2.2% -0.7% Stock Analytics
DR REDDYS LABORATORIES ₹103,522.0 Cr -1.5% -5.9% -5.1% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

0.9%

23.4%

44.3%

SENSEX

-0.5%

-0.3%

1%


You may also like the below Video Courses